Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



GENELUX Corp Create: Alert

All | News | Filings
Date FiledTypeDescription
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/04/2023 4 Szalay Aladar (10% Owner) has filed a Form 4 on GENELUX Corp
Txns: Sold 75,690 shares @ $25.4885, valued at $1.9M
10/04/2023 4 Jewett Caroline (Head of Quality) has filed a Form 4 on GENELUX Corp
Txns: Granted 22,000 options to buy @ $24.75, valued at $544.5k
09/29/2023 4 Szalay Aladar (10% Owner) has filed a Form 4 on GENELUX Corp
Txns: Sold 11,257 shares @ $24.47, valued at $275.5k
Sold 2,289 shares @ $24.12, valued at $55.2k
09/27/2023 4 Szalay Aladar (10% Owner) has filed a Form 4 on GENELUX Corp
Txns: Sold 3,947 shares @ $24.82, valued at $98k
Sold 5,511 shares @ $25.75, valued at $141.9k
Sold 1,900 shares @ $26.6, valued at $50.5k
Sold 1,100 shares @ $27.81, valued at $30.6k
Sold 7,465 shares @ $22.47, valued at $167.7k
Sold 12,740 shares @ $24.03, valued at $306.1k
Sold 9,600 shares @ $24.51, valued at $235.3k
09/27/2023 4 Yu Yong (VP, Clinical Trial Operations) has filed a Form 4 on GENELUX Corp
Txns: Sold 1,883 shares @ $22.5397, valued at $42.4k
Sold 1,114 shares @ $23.5145, valued at $26.2k
Sold 2,203 shares @ $24.4623, valued at $53.9k
Exercised 5,200 options to buy @ $6, valued at $31.2k
08/22/2023 4 Jewett Caroline (Head of Quality) has filed a Form 4 on GENELUX Corp
Txns: Sold 515 shares @ $23.73, valued at $12.2k
08/22/2023 4 Smalling Ralph (Head of Regulatory) has filed a Form 4 on GENELUX Corp
Txns: Sold 935 shares @ $23.73, valued at $22.2k
08/22/2023 4 Samuelson Doug (CFO) has filed a Form 4 on GENELUX Corp
Txns: Sold 1,297 shares @ $23.73, valued at $30.8k
08/22/2023 4 Ryder Sean (General Counsel) has filed a Form 4 on GENELUX Corp
Txns: Sold 328 shares @ $23.73, valued at $7.8k
08/22/2023 4 Cappello Joseph (VP, Pharmaceutical Development) has filed a Form 4 on GENELUX Corp
Txns: Sold 3,265 shares @ $23.73, valued at $77.5k
08/22/2023 4 Yu Yong (VP, Clinical Trial Operations) has filed a Form 4 on GENELUX Corp
Txns: Sold 3,265 shares @ $23.73, valued at $77.5k
08/22/2023 4 Zindrick Thomas (President and CEO) has filed a Form 4 on GENELUX Corp
Txns: Sold 8,349 shares @ $23.73, valued at $198.1k
05/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/02/2023 4 Mirabelli Mary (Director) has filed a Form 4 on GENELUX CORP
Txns: Granted 1,000 shares @ $0
05/02/2023 4 Woodward Gabe (Director) has filed a Form 4 on GENELUX CORP
Txns: Granted 1,000 shares @ $0
05/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/02/2023 4 Zhang Qian (Associate VP, Research) has filed a Form 4 on GENELUX CORP
Txns: Granted 6,000 shares @ $0
05/02/2023 4 Ryder Sean (General Counsel) has filed a Form 4 on GENELUX CORP
Txns: Granted 900 shares @ $0
05/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/02/2023 4 Yu Tony (VP, Clinical Trial Operations) has filed a Form 4 on GENELUX CORP
Txns: Granted 9,000 shares @ $0
05/02/2023 4 Cappello Joseph (VP, Pharmaceutical Development) has filed a Form 4 on GENELUX CORP
Txns: Granted 9,000 shares @ $0
01/31/2023 4 Zhang Qian (Associate VP, Research) has filed a Form 4 on GENELUX CORP
Txns: Bought 200 shares @ $6.2485, valued at $1.2k
01/30/2023 4 Szalay Aladar (10% Owner) has filed a Form 4 on GENELUX CORP
Txns: Converted 500,000 shares @ $0
Converted 500,000 shares @ $0
Converted 1,500,000 preferred shares @ $0
Converted 1,500,000 preferred shares @ $0
01/30/2023 4 Thomas John (Director) has filed a Form 4 on GENELUX CORP
Txns: Converted 470,000 shares @ $0
Converted 1,410,000 preferred shares @ $0
01/30/2023 4 Woodward Gabe (Director) has filed a Form 4 on GENELUX CORP
Txns: Converted 5,378 shares @ $0
Converted 3,186 shares @ $0
Converted 2,798 shares @ $0
Converted 13,000 options to buy @ $0
Converted 7,000 options to buy @ $0
Converted 6,000 options to buy @ $0

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy